Cost-effectiveness analysis and incremental cost-effectiveness ratios: uses and pitfalls

被引:44
|
作者
Bambha, K [1 ]
Kim, WR [1 ]
机构
[1] Mayo Clin & Mayo Fdn, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA
关键词
cost-effectiveness; economic analysis; incremental cost-effectiveness ratio; costs; sensitivity analysis; discounting; health care costs;
D O I
10.1097/00042737-200406000-00003
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Cost-effectiveness analysis is a formal method of comparing alternative medical interventions with regard to their resource utilization (costs) and outcomes (effectiveness). The incremental cost-effectiveness ratio is an informative measure generated from such an analysis and represents the ratio of the difference in cost between two medical interventions to the difference in outcomes between the two interventions. Thus, the incremental cost-effectiveness ratio summarizes the additional cost per unit of health benefit gained in switching from one medical intervention to another. Although incremental cost-effectiveness ratios have limitations, when used in the proper context, these ratios serve as one of the important tools needed to help guide decisions about allocating scarce resources across competing medical programmes. (C) 2004 Lippincott Williams Wilkins.
引用
收藏
页码:519 / 526
页数:8
相关论文
共 50 条
  • [41] WHAT IS COST-EFFECTIVENESS ANALYSIS
    EVANS, DB
    MEDICAL JOURNAL OF AUSTRALIA, 1990, 153 : S7 - S9
  • [42] ANALYSIS OF THE COST-EFFECTIVENESS OF PACS
    HILSENRATH, PE
    SMITH, WL
    BERBAUM, KS
    FRANKEN, EA
    OWEN, DA
    AMERICAN JOURNAL OF ROENTGENOLOGY, 1991, 156 (01) : 177 - 180
  • [43] THE ANATOMY OF COST-EFFECTIVENESS ANALYSIS
    PETERSON, RD
    EVALUATION REVIEW, 1986, 10 (01) : 29 - 44
  • [44] Medicare and cost-effectiveness analysis
    Neumann, PJ
    Rosen, AB
    Weinstein, MC
    NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (14): : 1516 - 1522
  • [45] DECISION AND COST-EFFECTIVENESS ANALYSIS
    MARLEY, DS
    JOURNAL OF FAMILY PRACTICE, 1990, 30 (02): : 233 - &
  • [46] COST-EFFECTIVENESS ANALYSIS - A REVIEW
    RUTIGLIANO, MJ
    NEUROSURGERY, 1995, 37 (03) : 436 - 443
  • [47] THE ROAD TO COST-EFFECTIVENESS ANALYSIS
    KLARMAN, HE
    MILBANK MEMORIAL FUND QUARTERLY-HEALTH AND SOCIETY, 1982, 60 (04): : 585 - 603
  • [48] Overview of Cost-effectiveness Analysis
    Sanders, Gillian D.
    Maciejewski, Matthew L.
    Basu, Anirban
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 321 (14): : 1400 - 1401
  • [49] Cost-effectiveness analysis of paclitaxel
    Eandi, Mario
    FARMECONOMIA-HEALTH ECONOMICS AND THERAPEUTIC PATHWAYS, 2006, 7 (02) : 97 - 117
  • [50] Is cost-effectiveness analysis unfair?
    Russell, LB
    MEDICAL DECISION MAKING, 2004, 24 (02) : 232 - 234